AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22682697 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (25 NHs)
Number of subjects: 4515
Study 22682697 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (25 NHs)
Number of subjects: 4515
Study 22682697 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 4515
Study 20135623 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal orthosis (Thämert Osteo‐Med) for 6 months
Number of subjects: 72
Study 20135623 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 72
Study 18614558 — intervention group
Group type: EXPERIMENTAL
Intervention: Group asthma education-exercise programme
Number of subjects: 36
Study 16027537 — intervention group
Group type: EXPERIMENTAL
Intervention: CD-ROM educational program for sexual violence prevention (n = 39)
Number of subjects: 79
Study 16027537 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 40)
Number of subjects: 79
Study 12516830 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF+EMD group (Emdogain with coronally advanced flap)
Number of subjects: 14
Study 12516830 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF+CTG+EMD group (Emdogain with coronally advanced flap and subepithelial connective tissue graft)
Number of subjects: 14
Study 12516830 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF+EMD group
Number of subjects: 14
Study 12516830 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF+CTG+EMD group
Number of subjects: 14
Study 12516830 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study 10636368 — intervention group
Group type: EXPERIMENTAL
Intervention: Information video
Number of subjects: 150
Study 10636368 — intervention group
Group type: COMPARATOR
Intervention: No video
Number of subjects: 150
Study 7492835 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 2019772 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus amikacin (CA)
Number of subjects: 747
Study 2019772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime plus amikacin plus vancomycin (CAV)
Number of subjects: 747
Study 6160345 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose furosemide (40 mg/day)
Number of subjects: 12
Study 6160345 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6160345 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (no therapy)
Number of subjects: 12
Study 31116151 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin mesylate GITS (4 mg/day)
Number of subjects: 36
Study 31116151 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine GITS (30 mg/day)
Number of subjects: 36
Study 28694153 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free energy drink (SFED)
Number of subjects: 14
Study 28694153 — intervention group
Group type: COMPARATOR
Intervention: Dummy drink (control)
Number of subjects: 14
Study 25928214 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous steroids
Number of subjects: 1695
Study 25928214 — intervention group
Group type: EXPERIMENTAL
Intervention: DrotAA + steroids
Number of subjects: 1695
Study 25928214 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo + steroids
Number of subjects: 1695
Study 25928214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1695
Study 23648079 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted program for MRSA infection prevention
Number of subjects: 159
Study 21896127 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipohydroxyacid peels
Number of subjects: 20
Study 21896127 — intervention group
Group type: COMPARATOR
Intervention: Salicylic acid peels
Number of subjects: 20
Study 20043571 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 10
Study 20043571 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic ultrasound (US)
Number of subjects: 10
Study 17207038 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical preventer medication
Number of subjects: 57
Study 17207038 — intervention group
Group type: COMPARATOR
Intervention: Current inhaled corticosteroid medication
Number of subjects: 57
Study 17207038 — intervention group
Group type: COMPARATOR
Intervention: No asthma medication
Number of subjects: 57
Study 15146933 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinastine hydrochloride (20 mg/day, once daily)
Number of subjects: 0
Study 15146933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11464687 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure measurements
Number of subjects: 0
Study 11464687 — intervention group
Group type: COMPARATOR
Intervention: Blood pressure measurements in the surgery
Number of subjects: 0
Study 9847466 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous hyperfractionated accelerated radiotherapy
Number of subjects: 58
Study 9847466 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 58
Study 8017354 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 77
Study 8017354 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg)
Number of subjects: 77
Study 8017354 — intervention group
Group type: COMPARATOR
Intervention: Placebo (beta-lactose)
Number of subjects: 77
Study 2137406 — intervention group
Group type: EXPERIMENTAL
Intervention: Hulka clip via laparoscopy
Number of subjects: 499
Study 2137406 — intervention group
Group type: COMPARATOR
Intervention: Unipolar electrocoagulation (cautery) via laparoscopy
Number of subjects: 499
Study 2137406 — intervention group
Group type: COMPARATOR
Intervention: Tubal ring occlusion technique
Number of subjects: 499
Study 2137406 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall satisfaction with sterilization procedure
Number of subjects: 499
Study 2137406 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic or abdominal surgeries post-sterilization
Number of subjects: 499
Study 29697447 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrectomy (LG)
Number of subjects: 610
Study 29697447 — intervention group
Group type: COMPARATOR
Intervention: Open gastrectomy (OG)
Number of subjects: 610
Study 28042082 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR)
Number of subjects: 9
Study 28042082 — intervention group
Group type: COMPARATOR
Intervention: Chard gel (GEL)
Number of subjects: 9
Study 26187617 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX
Number of subjects: 3018
Study 24053706 — intervention group
Group type: EXPERIMENTAL
Intervention: SLIT (sublingual immunotherapy)
Number of subjects: 30
Study 24053706 — intervention group
Group type: EXPERIMENTAL
Intervention: SCIT (subcutaneous immunotherapy)
Number of subjects: 30
Study 24053706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 21703676 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment with subcutaneous enoxaparin (≥5 days) followed by oral anticoagulation (≥90 days)
Number of subjects: 344
Study 21703676 — intervention group
Group type: COMPARATOR
Intervention: Inpatient treatment with subcutaneous enoxaparin (≥5 days) followed by oral anticoagulation (≥90 days)
Number of subjects: 344
Study 21703676 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 344
Study 21703676 — intervention group
Group type: COMPARATOR
Intervention: Inpatient treatment
Number of subjects: 344
Study 19231298 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong (24 sessions over 3 months)
Number of subjects: 117
Study 19231298 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy (24 sessions over 3 months)
Number of subjects: 117
Study 19231298 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 117
Study 17960627 — intervention group
Group type: EXPERIMENTAL
Intervention: Mynx extravascular sealant
Number of subjects: 190
Study 15142202 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg am and 30 mg pm for 7 days
Number of subjects: 40
Study 15142202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15142202 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 40
Study 11114574 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (500 mg/day) for 3 months
Number of subjects: 14
Study 9496487 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized oral desensitization program
Number of subjects: 14
Study 9496487 — intervention group
Group type: COMPARATOR
Intervention: Strict elimination diet regimen (Control)
Number of subjects: 14
Study 7766945 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylalanine-restricted diet, maintaining maternal blood phenylalanine levels between 120 and 360 mumol/l before conception and during pregnancy.
Number of subjects: 402
Study 2924230 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement in establishing criteria (15 physicians)
Number of subjects: 40
Study 2924230 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving criteria by mail (15 physicians)
Number of subjects: 40
Study 2924230 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 physicians)
Number of subjects: 40
Study 1123173 — intervention group
Group type: EXPERIMENTAL
Intervention: Metiamide (histamine H2-receptor antagonist)
Number of subjects: 0
Study 31537420 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg/kg
Number of subjects: 90
Study 31537420 — intervention group
Group type: COMPARATOR
Intervention: suxamethonium 1 mg/kg
Number of subjects: 90
Study 31102925 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai Boxing dance (TBD) program for 4 weeks
Number of subjects: 78
Study 31102925 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving a fall prevention booklet
Number of subjects: 78
Study 28617540 — intervention group
Group type: EXPERIMENTAL
Intervention: PM2.5 group
Number of subjects: 96
Study 28617540 — intervention group
Group type: EXPERIMENTAL
Intervention: House dust mite antigen group
Number of subjects: 96
Study 28617540 — intervention group
Group type: EXPERIMENTAL
Intervention: Synergistic group
Number of subjects: 96
Study 28617540 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 25848237 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation with Behavioral Activation (PsyED-BA)
Number of subjects: 62
Study 25848237 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation only (PsyED only)
Number of subjects: 62
Study 23623520 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge coordinator intervention
Number of subjects: 253
Study 23623520 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 253
Study 21719783 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 300 mg/d
Number of subjects: 67
Study 21719783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 19700995 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaptive film (Steri Strip S; 3M company)
Number of subjects: 8
Study 19700995 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular monocryl sutures (4‐0 intracuticular monocryl sutures)
Number of subjects: 8
Study 19700995 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaptive film
Number of subjects: 8
Study 19700995 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular monocryl sutures
Number of subjects: 8
Study 19700995 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaptive film and Subcuticular monocryl sutures
Number of subjects: 8
Study 16676704 — intervention group
Group type: EXPERIMENTAL
Intervention: H‐Pro (high protein diet)
Number of subjects: 7
Study 16676704 — intervention group
Group type: COMPARATOR
Intervention: H‐CHO (high carbohydrate diet)
Number of subjects: 7
Study 15534246 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 2356
Study 15534246 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use in participants with at least one APOE-epsilon4 allele who entered the study before age 80
Number of subjects: 2356
Study 11521932 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy shock-wave therapy (ESWT), 6,000 impulses (energy flux density, 0.11 mJ/mm2) in three sessions after local anaesthesia
Number of subjects: 40
Study 11521932 — intervention group
Group type: COMPARATOR
Intervention: Sham ESWT, 6,000 impulses after local anaesthesia
Number of subjects: 40
Study 9314428 — intervention group
Group type: EXPERIMENTAL
Intervention: Low mean arterial pressure (MAP) goal of < or = 92 mm Hg
Number of subjects: 548
Study 9314428 — intervention group
Group type: COMPARATOR
Intervention: Usual blood pressure group
Number of subjects: 548
Study 9314428 — intervention group
Group type: EXPERIMENTAL
Intervention: Low MAP goal
Number of subjects: 548
Study 9314428 — intervention group
Group type: EXPERIMENTAL
Intervention: Both blood pressure groups combined
Number of subjects: 548
Study 8420275 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrohydraulic lithotripter
Number of subjects: 60
Study 8420275 — intervention group
Group type: COMPARATOR
Intervention: Piezoelectric lithotripter
Number of subjects: 60
Study 8420275 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lithotripters
Number of subjects: 60
Study 3946248 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 to 300 mg/day)
Number of subjects: 39
Study 3946248 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (5 to 15 mg/day)
Number of subjects: 39
Study 28881294 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 482
Study 28881294 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 482
Study 26890894 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 267
Study 26890894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 24452085 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical calf muscle stimulation (EMS) with Veinoplus device for >100 minutes per day (>5 sessions)
Number of subjects: 80
Study 24452085 — intervention group
Group type: COMPARATOR
Intervention: Control group with graduated middle stretch compression bandage and low dose unfractionated heparin (LDUH) injections
Number of subjects: 80
Study 24452085 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical calf muscle stimulation (EMS) with Veinoplus device
Number of subjects: 80
Study 24452085 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with baseline thrombosis who underwent EMS
Number of subjects: 80
Study 24452085 — intervention group
Group type: COMPARATOR
Intervention: Control group without EMS
Number of subjects: 80
Study 22166961 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 45
Study 22166961 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling with handout
Number of subjects: 45
Study 22166961 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling with video
Number of subjects: 45
Study 20044067 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic prescription for calcium carbonate with vitamin D supplement
Number of subjects: 245
Study 20044067 — intervention group
Group type: COMPARATOR
Intervention: Verbal counseling about calcium supplementation
Number of subjects: 245
Study 19080566 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoCPAP treatment for 1 month
Number of subjects: 50
Study 19080566 — intervention group
Group type: EXPERIMENTAL
Intervention: ASV treatment for 1 week
Number of subjects: 50
Study 19080566 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma TNF-alpha levels
Number of subjects: 50
Study 16719171 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosphamide (IF) treatment in doses from 1.5 g/m2 to 3 g/m2 for 3 to 5 days.
Number of subjects: 76
Study 12869359 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen (3 L/minute)
Number of subjects: 29
Study 12869359 — intervention group
Group type: COMPARATOR
Intervention: Air (3 L/minute)
Number of subjects: 29
Study 10868714 — intervention group
Group type: EXPERIMENTAL
Intervention: Easi-Breathe inhaler
Number of subjects: 100
Study 10868714 — intervention group
Group type: EXPERIMENTAL
Intervention: Autohaler inhaler
Number of subjects: 100
Study 10868714 — intervention group
Group type: COMPARATOR
Intervention: Pressurized metered dose inhaler (pMDI)
Number of subjects: 100
Study 10868714 — intervention group
Group type: EXPERIMENTAL
Intervention: Clickhaler inhaler
Number of subjects: 100
Study 10868714 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuhaler inhaler
Number of subjects: 100
Study 10868714 — intervention group
Group type: COMPARATOR
Intervention: pMDI
Number of subjects: 100
Study 8647496 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical ultrasonography
Number of subjects: 0
Study 8647496 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasonography
Number of subjects: 0
Study 8647496 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography with compression test
Number of subjects: 0
Study 2067212 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 48
Study 2067212 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic uremic patients undergoing their first dialysis session
Number of subjects: 48
Study 2067212 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibody (mAb) against human IL-6
Number of subjects: 48
Study 2067212 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis (first session and subsequent sessions)
Number of subjects: 48
Study 2067212 — intervention group
Group type: EXPERIMENTAL
Intervention: Nature of dialysis membrane (cellulosic or synthetic polyacrilonitrile)
Number of subjects: 48
Study 6437128 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol 400 mg
Number of subjects: 12
Study 6437128 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol 600 mg
Number of subjects: 12
Study 6437128 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol 800 mg
Number of subjects: 12
Study 30040706 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ultrasound therapy in addition to hotpack, TENS, and exercise
Number of subjects: 30
Study 30040706 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound in addition to hotpack, TENS, and exercise
Number of subjects: 30
Study 26822613 — intervention group
Group type: EXPERIMENTAL
Intervention: AVX-470 (0.2, 1.6 or 3.5g/day)
Number of subjects: 37
Study 26822613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 26822613 — intervention group
Group type: EXPERIMENTAL
Intervention: AVX-470 (3.5g/day)
Number of subjects: 37
Study 24485476 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 106
Study 24485476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 22280514 — intervention group
Group type: EXPERIMENTAL
Intervention: SMARTSteps-ONLY
Number of subjects: 362
Study 22280514 — intervention group
Group type: EXPERIMENTAL
Intervention: SMARTSteps-PLUS
Number of subjects: 362
Study 22280514 — intervention group
Group type: COMPARATOR
Intervention: Wait-list
Number of subjects: 362
Study 22280514 — intervention group
Group type: EXPERIMENTAL
Intervention: SMARTSteps-ONLY and SMARTSteps-PLUS
Number of subjects: 362
Study 22280514 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 362
Study 20630656 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of morphine with an NMDA‐receptor antagonist
Number of subjects: 0
Study 20630656 — intervention group
Group type: COMPARATOR
Intervention: Morphine and placebo
Number of subjects: 0
Study 17506978 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination task
Number of subjects: 0
Study 17506978 — intervention group
Group type: COMPARATOR
Intervention: Distraction task
Number of subjects: 0
Study 17506978 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative rumination task
Number of subjects: 0
Study 17506978 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive rumination task
Number of subjects: 0
Study 16142134 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed pushing
Number of subjects: 0
Study 16142134 — intervention group
Group type: COMPARATOR
Intervention: Immediate pushing
Number of subjects: 0
Study 12518850 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine‐pyrimethamine (SP) treatment
Number of subjects: 0
Study 12518850 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 0
Study 9706827 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy administered in prehospital setting (Gr.1)
Number of subjects: 280
Study 9706827 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic therapy administered in hospital setting (Gr.2)
Number of subjects: 280
Study 7633137 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin with the mother
Number of subjects: 0
Study 7633137 — intervention group
Group type: EXPERIMENTAL
Intervention: Cot care for the first 45 min, then skin-to-skin with the mother
Number of subjects: 0
Study 7633137 — intervention group
Group type: COMPARATOR
Intervention: Cot care
Number of subjects: 0
Study 2653174 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.3 mg per os)
Number of subjects: 10
Study 9291 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg/day
Number of subjects: 5
Study 9291 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone 50 mg/day
Number of subjects: 5
Study 9291 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone 100 mg/day
Number of subjects: 5
Study 9291 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone 200 mg/day
Number of subjects: 5
Study 9291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 31486103 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine for 6 weeks
Number of subjects: 80
Study 31486103 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 80
Study 30616461 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial glycemia
Number of subjects: 45
Study 30616461 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetuin-A
Number of subjects: 45
Study 30616461 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline calcium score
Number of subjects: 45
Study 30616461 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium score at 18 months
Number of subjects: 45